Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00834509 · ClinicalTrials.gov registry record
Biomarkers for Obstructive Sleep Apnea
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 181
- Enrollment target
NCT00834509: Completed study, sponsored by University of Pennsylvania.
NCT00834509 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 181 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00834509 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 181 participants
- Enrollment target
Study Summary
The purpose of the study is to: * recruit subjects with untreated sleep apnea; assess overnight changes in their blood and urine chemicals * review the overnight changes in blood and urine chemicals after they have been treated for sleep apnea * assess the overnight changes in blood and urine chemicals in healthy individuals with no sleep problems * compare the amount of fat in the belly using a Magnetic Resonance Imaging (MRI) scanner on all subjects
Interventions
- DEVICE CPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 181 participants |
| Start Date | 2008-04 |
| Est. Completion | 2015-02-01 |
What the finished NCT00834509 record still lists
NCT00834509 is an observational study that tracks outcomes without assigning an intervention. The registered 181 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which CPAP is the first listed.
NCT00834509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00834509 about?
NCT00834509 is a clinical study titled "Biomarkers for Obstructive Sleep Apnea". The purpose of the study is to: * recruit subjects with untreated sleep apnea; assess overnight changes in their blood and urine chemicals * review the overnight changes in blood and urine chemicals after they have been treated for sleep apnea * assess the overnight changes in blood and urine chemi...
What is the current status of trial NCT00834509?
This trial is currently completed. The enrollment target is 181 participants. The study started on 2008-04. Estimated completion is 2015-02-01.
What interventions are being tested in trial NCT00834509?
The interventions under investigation include: CPAP (DEVICE).
Who is sponsoring clinical trial NCT00834509?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04578392 · 181 participants · NA
MeSenteric SpAring Versus High Ligation Ileocolic Resection for the Prevention of REcurrent Crohn's DiseaSe (SPARES)
- NCT05597891 · 181 participants · NA
Endovascular Engineering ENGULF Study
- NCT03897998 · 182 participants · Phase 2
Neural Correlates of Hypoalgesia Driven by Observation
- NCT04300556 · 182 participants · Phase 1
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia